期刊文献+

白喉毒素DAB_(389)-(Gly_4Ser)_2-α-促黑激素工程菌发酵条件的初步研究 被引量:1

Preliminary Study on Fermentation Conditions of the Recombinant Diphtheria Toxin DAB_(389)-(Gly_4Ser)_2-α-Melanophore-Stimulating Hormone
下载PDF
导出
摘要 目的:为了提高融合蛋白白喉毒素DAB389-(Gly4Ser)2-α-促黑激素的表达量,研究工程菌发酵条件的最优化。方法:利用三角瓶模拟小剂量发酵,在不同的受体菌、培养基、培养温度、时间、pH值、诱导剂浓度、诱导时间和温度等因素变化下研究目的蛋白的表达量。结果:工程菌优化的发酵条件为:最佳表达菌种为大肠杆菌BL21(λDE3),最适宜的培养基为M9B2,适合的pH值为7.0~7.4,最佳诱导温度为30℃,诱导时间为6 h,诱导剂IPTG的最佳用量为1.4 mmol/L。结论:获得了DAB389-(Gly4Ser)2-α-促黑素细胞激素工程菌的最优化发酵条件,为中试放大提供了理论依据。 Objective: In order to research on the highest expression of recombinant diphtheria toxin DAB389-(Gly4Ser)2- α-melanophore-stimulating hormone, the optimezed fermentation conditions of recombinant bacteria were studied. Methods: The fermentation conditions were investigated on the expression of protein in shake flask scale under different bacterical lines, culture medium, tempreture, culture time, pH, inducing concentration, inducing time and inducing tempreture etc. Results: Based on the experiments, there were the optimezed fermentation conditions such as that bacterical lines was E. coli BL21(λDE3), culture medium was M9B2, pH was adjusted 7.0-7.4, inducing tempreture and time was 30℃ and 6 h respectively, IPTG was 1.4 mmol/L. Conclusion: The results showed that the optimezed fermentation conditions were established, which supplied a good tool for the magnify of recombinant bacteria.
出处 《生物技术通讯》 CAS 2008年第1期55-58,共4页 Letters in Biotechnology
基金 吉林省教育厅资助课题 吉林农业大学科学研究启动基金项目
关键词 α-促黑激素 白喉毒素 融合蛋白 工程菌 发酵 条件优化 α-melanophore-stimulating hormone diphtheria toxin refused protein recombinant bacteria fermentation optimized conditions
  • 相关文献

参考文献9

二级参考文献26

  • 1刘金生,王郡甫,许晓群,游力,张彩,高春义.重组人白细胞介素-15包涵体离子交换柱复性与稀释复性的比较[J].中国生化药物杂志,2005,26(2):84-85. 被引量:6
  • 2Pufe T,Wildemann B,Petersen W,et al. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat[J]. Cell Tissue Res,2002,309(3):387-392. 被引量:1
  • 3Miyanishi K,Trindade MC,Ma T,et al. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles[J]. J Bone Miner Res,2003,18(9):1573-1583. 被引量:1
  • 4Furumatsu T,Shen ZN, Kawai A,et al. Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis[J]. J Biochem,2003,133(5):633-639. 被引量:1
  • 5Neufeld G,Cohen T,Gengrinovitch S,et al.Vascular endothelial growth factor(VEGF)and its receptors[J]. FASEB J,1999,13(1):9-22. 被引量:1
  • 6Gitay GH,Cohen T,Tessler S,et al. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells[J].J Biol Chem,1996,(271):5519-5523. 被引量:1
  • 7Leung DW,Cachlanes G,Kuang WJ,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen[J]. Science,1989,246:1306-1309. 被引量:1
  • 8Cohen T,Gitai GH,Neufeld G,et al. High levels of biologically active vascular endothelial growth factor (VEGF)are produced by the baculovirus expression system[J].Growth Factors,1992,7(2):131-138. 被引量:1
  • 9Lu E,Wagner WR,Schellenberger U,et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue[J].Circulation,2003,108(1):97-103. 被引量:1
  • 10Okamura H, Nagata K, Komatsu T, et al. A novel constimulatory factor for γ-interferon induction found in the live of mice causes endotoxic shock[J]. Infect Immun, 1995,63:3996-3972. 被引量:1

共引文献15

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部